However, it has been shown that there is a very low concordance in BRAF, KRAS, NRAS and TERT promoter mutations between primary or metastatic thyroid tissues and plasma ctDNAs in early stage thyroid cancer patients [165]. The gene discussed is TERT; the disease is thyroid cancer.